Motoi Okada, Ha Won Kim, Kaoru Matsu-Ura, Yi-Gang Wang, Meifeng Xu, Muhammad Ashraf. Abrogation of Age-Induced MicroRNA-195 Rejuvenates the Senescent Mesenchymal Stem Cells by Reactivating Telomerase. STEM CELLS. 2016. 34. 1. 148-159
Motoi Okada, Satoshi Kawaguchi, Yuta Kashiwagi, Kentaro Hayashi, Satoshi Fujita, Naoyuki Hasebe. Carvedilol Improves Prognosis in Sepsis-induced Cardiomyopathy Through the Activation of "telomere-p53-pgc Signaling". CIRCULATION. 2016. 134
Hideyuki Kondo, Ha Won Kim, Lei Wang, Motoi Okada, Ronald W. Millard, Tohru Masuyama, Yigang Wang. Blockade of Senescence-associated Microrna-195 in Aged Skeletal Myoblasts Facilitates Reprogramming to Produce Induced Pluripotent Stem Cells. CIRCULATION. 2015. 132
Motoi Okada, Hawon Kim, Muhammad Ashraf, Jun-ichi Kawabe, Naoyuki Hasebe. Abrogation of miR-195 Improves Function in Aged Heart by Preventing Telomere Shortening and Mitochondrial Dysfunction. CIRCULATION. 2014. 130
Ha Won Kim, Motoi Okada, Kaoru Matsu-ura, Muhammad Ashraf. Resetting Aging Clock in the Senescent Stem Cells by Suppressing Microrna-146a Promotes Cardiomyogenesis in the Ischemic Heart. CIRCULATION. 2013. 128. 22
Sanjay Kumar, Motoi Okada, Dehua Chang, Muhammad Ashraf. A Novel Phosphorylating Mechanism of STAT3 in Protection against Ischemia/reperfusion by Pharmacological Preconditioning With Tadalafil, a PDE Inhibitor. CIRCULATION. 2013. 128. 22
Transcriptional Repression of Protein Kinase G during Ischemic-Reperfusion Injury in Stem Cells is Restored by Inhibition of Phosphodiesterase 5A with Long Acting Tadalafil
(AHA 2012)
Senescence-Associated microRNA-146a Suppresses Cardiomyogenic Potential by Targeting Notch1: Insights from Small Juvenile Stem Cells
(AHA 2012)
Rejuvenation of Aged Bone Marrow Stem Cells with Microrna-195 for Cardiac Repair
(AHA 2012)
Mitochondrial Transgenic Expression of Connexin 43 Confers Cytoprotection to he Stem Cells and Cardiomyocytes in Ischemic Myocardium
(AHA 2011)
Existence of Small Juvenile Cells in the Aging Bone Marrow Stromal Cells and Their Therapeutic Potential for Ischemic Heart Disease
(AHA 2011)